Credit Suisse Ag Immuno Precise Antibodies Ltd. Transaction History

Credit Suisse Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.64 - $6.49 $215,386 - $384,026	-59,172 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.06 - $6.69 $150,064 - $198,405	-29,657 Reduced 33.39%	59,172 $317,000
Q3 2021 Nov 12, 2021	BUY	$5.14 - $13.22 $258,058 - $663,723	50,206 Added 129.99%	88,829 $553,000
Q2 2021 Aug 16, 2021	BUY	$6.02 - $12.91 $31,303 - $67,132	5,200 Added 15.56%	38,623 $233,000
Q1 2021 May 14, 2021	BUY	$8.84 - $17.0 $295,459 - $568,191	33,423 New	33,423 $328,000

1.9M

Ticker IPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,836,700
Market Cap $10.2M
Description
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.